Could the COVID-19 infection have a better prognosis than expected in pediatric hematology oncology and bone marrow transplant patients?

Kaynakça (8)

1. Huang C, Wang Y, Li X, et al. Clinical features of patients with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395: 497-506
2. Balduzzi A, Brivio E, Rovelli A, et al. Lessons after the early management of the COVID-19 outbreak in a pediatric transplant and hemato-oncology centre embedded within a COVID-19 dedicated hospital in Lombardia, Italy. Bone Marrow Transplantation 2020; 55: 1900-5
3. T.C. Ministry of Health General Office of National Health COVID-19 Guideline http://www.covid19bilgi.saglik.gov.tr/depo/rehberler/ COVID-19_Rehberi.pdf
4. Tan YP, Tan BY, Pan J, et al. Epidemiologic and clinical characteristics of 10 children with coronavirus disease 2019 in Changsha, China. J Clin Virol 2020; 127: 104253. https://doi.org/10.1016/j. jcv.2020.104353
5. Çokuğraş H, Önal P. SARS-CoV-2 infection in children. Türk Pediatri Ars 2020; 55: 95-102
6. Wolfs TFW, Attarbachi A, Balduzzi A et al. COVID-19 Impact on childhood haematology patients. Hemasphere 2020; 4: e465
7. Bisogno G, Provenzi M, Zama D et al. Clinical characteristics and outcome of severe acute respiratory syndrome coronavirus 2 infection in Italian pediatric oncology patients: A study from the infectious diseases working group of the associazione Italiana di oncologia e ematologia pediatrica. J Pediatric Infect Dis Soc 2020; 9: 530-4
8. Zheng S, Fan J, Yu F, et al. Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: Retrospective cohort study. BMJ 2020; 369: m1443.